ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,151Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 86

$1.42M Total Retail Price of All Prescriptions

Rank: 12 out of 86

737 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

9% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 14,859 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $288 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 1,256 1,030 1 3
SIMVASTATIN 655 582 2 5
OMEPRAZOLE 633 551 3 8
MELOXICAM 533 420 4 27
DIOVAN HCT 474 403 5 20
FUROSEMIDE 346 275 6 21
ATORVASTATIN CALCIUM 339 302 7 12
CLOPIDOGREL 336 277 8 34
ZOLPIDEM TARTRATE 332 281 9 11
ALENDRONATE SODIUM 318 312 10 29
METFORMIN HCL 310 260 11 17
PROAIR HFA 307 156 12 19
METOPROLOL SUCCINATE 298 261 13 15
AZITHROMYCIN 293 244 14 28
CRESTOR 274 210 15 9
NEXIUM 261 170 16 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 260 215 17 67
DONEPEZIL HCL 252 228 18 74
TAMSULOSIN HCL 246 234 19 45
DIOVAN 232 200 20 40
ADVAIR DISKUS 231 83 21 32
LEVOTHYROXINE SODIUM 224 190 22 16
CLONIDINE HCL 218 128 23 55
METOPROLOL TARTRATE 205 162 24 26
SINGULAIR 203 116 25 44
GLYBURIDE-METFORMIN HCL 191 146 R 26 59
POTASSIUM CHLORIDE 184 129 27 52
ENDOCET 164 81 S2 28 18
VOLTAREN 160 119 29 58
LEVOFLOXACIN 158 111 30 54
JANUVIA 157 113 31 37
ACETAMINOPHEN-CODEINE 155 118 S3 32 107
WARFARIN SODIUM 155 134 32 38
MONTELUKAST SODIUM 150 87 34 70
AVODART 149 137 35 110
PLAVIX 143 120 36 47
GLYBURIDE 133 104 R 37 90
TRICOR 132 119 38 76
HYDROCHLOROTHIAZIDE 131 122 39 22
GABAPENTIN 131 76 39 25
ATENOLOL 128 112 41 80
CYCLOBENZAPRINE HCL 125 82 R 42 85
AZELASTINE HCL 123 106 43 77
ENALAPRIL MALEATE 122 91 44 24
DIGOXIN 119 104 45 118
CARVEDILOL 118 73 46 52
MEGESTROL ACETATE 117 98 R 47 120
AMLODIPINE BESYLATE-BENAZEPRIL 114 91 48 64
TRAMADOL HCL 113 92 49 62
ALLOPURINOL 109 90 50 123
LACTULOSE 104 78 51 79
LIDODERM 102 87 52 75
FAMOTIDINE 100 84 53 81
LOVAZA 98 92 54 35
PAROXETINE HCL 96 88 55 131
CIPROFLOXACIN HCL 90 80 56 94
CELEBREX 89 75 57 61
AMOXICILLIN 89 74 57 133
LISINOPRIL 87 82 59 31
OXYCODONE-ACETAMINOPHEN 87 54 S2 59 66
NITROGLYCERIN PATCH 85 68 61 135
VALSARTAN-HYDROCHLOROTHIAZIDE 85 61 61 135
FLUTICASONE PROPIONATE 76 46 63 51
LIDOCAINE 75 57 64 148
RISPERIDONE 72 69 65 150
HALOBETASOL PROPIONATE 71 67 66 152
EXFORGE 67 53 67 88
MECLIZINE HCL 64 59 68 112
QUETIAPINE FUMARATE 63 35 69 160
LANTUS 62 51 70 116
LOSARTAN-HYDROCHLOROTHIAZIDE 61 54 71 41
PRAVASTATIN SODIUM 60 51 72 49
BISOPROLOL-HYDROCHLOROTHIAZIDE 60 49 72 161
LEVETIRACETAM 59 41 74 163
GLIMEPIRIDE 58 41 75 39
LEVOCETIRIZINE DIHYDROCHLORIDE 56 53 76 106
DEXILANT 55 48 77 104
OXYCODONE HCL 55 16 S2 77 33
CLOTRIMAZOLE-BETAMETHASONE 53 34 79 42
HYDRALAZINE HCL 52 48 80 179
LANTUS SOLOSTAR 52 30 80 124
NOVOLOG FLEXPEN 51 35 82 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.